Nucor, Sabra Health Care And A Major Investment Bank: CNBC's 'Final Trades'
Portfolio Pulse from Avi Kapoor
On CNBC's 'Halftime Report Final Trades,' analysts provided updates on Sabra Health Care REIT, Inc. (SBRA), The Goldman Sachs Group, Inc. (GS), and Nucor Corporation (NUE). Sabra Health Care has a 9% yield and 5% earnings growth, with a new Buy rating and $21 price target from Deutsche Bank. Goldman Sachs was upgraded by Morgan Stanley from Equal-Weight to Overweight with a price target increase to $449, while Oppenheimer raised their target to $506. Nucor reported strong quarterly earnings, beating estimates with $3.16 per share and sales of $7.70 billion. SBRA shares closed up 0.7%, GS shares rose 1.7%, and NUE shares gained 6.9% on Tuesday.
January 31, 2024 | 1:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Goldman Sachs was upgraded by Morgan Stanley to Overweight with a price target increase to $449, and Oppenheimer raised their target to $506.
The upgrades and increased price targets from reputable analysts suggest a strong bullish sentiment, which could drive Goldman Sachs' stock price up in the short term.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Nucor reported strong quarterly earnings, beating estimates with earnings of $3.16 per share and sales of $7.70 billion.
Nucor's better-than-expected earnings report is a strong positive signal for investors, likely contributing to continued upward momentum in the stock's price.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Sabra Health Care REIT has a 9% yield and 5% earnings growth, with a new Buy rating and $21 price target from Deutsche Bank.
The positive coverage and Buy rating from Deutsche Bank, along with a high yield, are likely to generate investor interest and could lead to a short-term increase in SBRA's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90